These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1941503)

  • 21. Transport mechanism of anthracycline derivatives in rat polymorphonuclear leukocytes: uptake of pirarubicin, daunorubicin and doxorubicin.
    Nagasawa K; Nomiyama M; Ohnishi N; Yokoyama T; Iwakawa S; Okumura K
    Biol Pharm Bull; 1994 Sep; 17(9):1305-8. PubMed ID: 7841960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrapleural pirarubicin (4'-O-tetrahydropyranyladriamycin) for treatment of malignant pleural effusion.
    Gotoh T; Tanaka Y; Fujita Y; Hiramori N; Fujii T; Arimoto T; Iwasaki Y; Fukabori T; Nakamura T; Ono N; Nakagawa M
    Jpn J Clin Oncol; 1996 Oct; 26(5):328-34. PubMed ID: 8895673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study.
    Thompson PA; Rosner GL; Matthay KK; Moore TB; Bomgaars LR; Ellis KJ; Renbarger J; Berg SL
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):243-51. PubMed ID: 19020877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chemical stability of pirarubicin in its use for continuous infusion].
    Leca F; Marchiset-Leca D; Nobili-Pieri N; Galeani A; Durieux-Joubert A
    Bull Cancer; 1996 Nov; 83(11):923-8. PubMed ID: 9033602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Augmentation of pirarubicin cytotoxicity by chlorpromazine in doxorubicin-resistant mouse P388 leukemia cells].
    Shibata H; Sano F; Furusawa S; Kawauchi H; Sasaki K; Takayanagi Y
    Yakugaku Zasshi; 1990 Sep; 110(9):678-81. PubMed ID: 2262880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Doxorubicin pharmacokinetics is correlated to the effect of induction therapy in children with acute myeloid leukemia.
    Palle J; Frost BM; Peterson C; Gustafsson G; Hellebostad M; Kanerva J; Schmiegelow K; Lönnerholm G;
    Anticancer Drugs; 2006 Apr; 17(4):385-92. PubMed ID: 16549995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of cardiac actions of doxorubicin, pirarubicin and aclarubicin in isolated guinea-pig heart.
    Temma K; Akera T; Chugun A; Kondo H; Hagane K; Hirano S
    Eur J Pharmacol; 1993 Apr; 234(2-3):173-81. PubMed ID: 8482324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of the interval between the administration of doxorubicin and paclitaxel on the pharmacokinetics of these drugs in patients with locally advanced breast cancer.
    Moreira A; Lobato R; Morais J; Silva S; Ribeiro J; Figueira A; Vale D; Sousa C; Araújo F; Fernandes A; Oliveira J; Passos-Coelho JL
    Cancer Chemother Pharmacol; 2001 Oct; 48(4):333-7. PubMed ID: 11710635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
    Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
    Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Copoly(styrene-maleic acid)-pirarubicin micelles: high tumor-targeting efficiency with little toxicity.
    Greish K; Nagamitsu A; Fang J; Maeda H
    Bioconjug Chem; 2005; 16(1):230-6. PubMed ID: 15656596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A sensitive and reproducible HPLC assay for doxorubicin and pirarubicin.
    Jacquet JM; Galtier M; Bressolle F; Jourdan J
    J Pharm Biomed Anal; 1992 May; 10(5):343-8. PubMed ID: 1511036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doxorubicin clearance in the obese.
    Rodvold KA; Rushing DA; Tewksbury DA
    J Clin Oncol; 1988 Aug; 6(8):1321-7. PubMed ID: 3411343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacokinetic profile of high-dose doxorubicin administered during a 6 h intravenous infusion in breast cancer patients].
    Wihlm J; Limacher JM; Levêque D; Duclos B; Dufour P; Bergerat JP; Methlin G
    Bull Cancer; 1997 Jun; 84(6):603-8. PubMed ID: 9295863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and metabolism of doxorubicin after short-term infusions in lymphoma patients.
    Andersen A; Holte H; Slørdal L
    Cancer Chemother Pharmacol; 1999; 44(5):422-6. PubMed ID: 10501917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of phenytoin on the pharmacokinetics of doxorubicin and doxorubicinol in the rabbit.
    Cusack BJ; Tesnohlidek DA; Loseke VL; Vestal RE; Brenner DE; Olson RD
    Cancer Chemother Pharmacol; 1988; 22(4):294-8. PubMed ID: 3168142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of intra-arterially administered pirarubicin in plasma and cerebrospinal fluid of patients with glioma.
    Morikawa N; Mori T; Takeyama M; Hori S
    Biol Pharm Bull; 1998 Mar; 21(3):297-9. PubMed ID: 9556164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxorubicin and doxorubicinol plasma concentrations and excretion in parotid saliva.
    Bressolle F; Jacquet JM; Galtier M; Jourdan J; Donadio D; Rossi JF
    Cancer Chemother Pharmacol; 1992; 30(3):215-8. PubMed ID: 1628370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intra-arterial hepatic chemotherapy with pirarubicin. Preclinical and clinical studies.
    Rougier P; Munck JN; Elias D; Herait P; Bognel C; Gosse C; Lasser P
    Am J Clin Oncol; 1990; 13 Suppl 1():S1-4. PubMed ID: 2291452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromatographic analysis and pharmacokinetics of liposome-encapsulated doxorubicin in non-small-cell lung cancer patients.
    Embree L; Gelmon KA; Lohr A; Mayer LD; Coldman AJ; Cullis PR; Palaitis W; Pilkiewicz F; Hudon NJ; Heggie JR
    J Pharm Sci; 1993 Jun; 82(6):627-34. PubMed ID: 8392545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of doxorubicin and its metabolite doxorubicinol in rabbits with induced acid and alkaline urine.
    Johansen PB; Jensen SE; Rasmussen SN; Dalmark M
    Cancer Chemother Pharmacol; 1984; 13(1):5-8. PubMed ID: 6329539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.